Cargando…
The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells
Despite advances in novel therapeutic approaches for the treatment of glioblastoma (GBM), the median survival of 12-14 months has not changed significantly. Therefore, there is an imperative need to identify molecular mechanisms that play a role in patient survival. Here, we analyzed the expression...
Autores principales: | Brodie, Shlomit, Lee, Hae Kyung, Jiang, Wei, Cazacu, Simona, Xiang, Cunli, Poisson, Laila M, Datta, Indrani, Kalkanis, Steve, Ginsberg, Doron, Brodie, Chaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458248/ https://www.ncbi.nlm.nih.gov/pubmed/28423669 http://dx.doi.org/10.18632/oncotarget.15991 |
Ejemplares similares
-
Correction: The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells
por: Brodie, Shlomit, et al.
Publicado: (2021) -
Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma
por: Jiang, Wei, et al.
Publicado: (2016) -
RasGRP3 regulates the migration of glioma cells via interaction with Arp3
por: Lee, Hae Kyung, et al.
Publicado: (2015) -
miR-504 modulates the stemness and mesenchymal transition of glioma stem cells and their interaction with microglia via delivery by extracellular vesicles
por: Bier, Ariel, et al.
Publicado: (2020) -
MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1
por: Bier, Ariel, et al.
Publicado: (2013)